Brought to you by:
Bryan Kay
Inari Medical, now part of Stryker, launches InThrill thrombectomy system
Inari Medical—now part of Stryker—has announced the launch of its next-generation InThrill thrombectomy system. The company stated in a recent press release that this is the “first and only purpose-built” small vessel and arteriovenous (AV) access thrombectomy system that can…
SVS highlights landmark paper on functional popliteal artery entrapment syndrome
The Society for Vascular Surgery has highlighted findings from a comprehensive 20-year clinical study that demonstrate treatment of functional popliteal artery entrapment syndrome—particularly in combination with fasciotomy for exertional compartment syndrome—has shown highly effective outcomes, with 82% of patients returning…
Getinge’s iCast covered stent system approved as bridging stent in US
Getinge recently announced that it has received Food and Drug Administration (FDA) premarket approval (PMA) for the iCast covered stent system. The device is now available as a bridging stent for the treatment of patients with aneurysmal disease. Getinge states…
Medtronic enrols first patient in Onyx liquid embolic IDE clinical study
Medtronic today announced that the first patient has been enrolled in the Peripheral Onyx liquid embolic (PELE) clinical trial, which will evaluate the safety and effectiveness of the Onyx liquid embolic system (LES) for embolization of arterial hemorrhage in the…
Medtronic to distribute FMD’s peripheral guidewires for transradial access in US
Medtronic today announced it has entered into an exclusive U.S. distribution agreement with Japan-based Future Medical Design Co (FMD) to sell specialty and workhorse peripheral guidewires. This agreement includes the first 400cm, 0.018″ peripheral guidewire available in the U.S., expanding…
Cook announces US launch of Zenith iliac branch device
Cook Medical has announced that its Zenith iliac branch device (ZBIS) is now commercially available in the U.S. with Food and Drug Administration (FDA) approval as an endovascular treatment option for aortoiliac or iliac aneurysmal disease. The company has also…
Vascular surgery history: Putting specialty on the map in a broader sense
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today formed the bedrock of the subject matter for this year’s John Homans Lecture—“Who put the vascular in vascular surgery?”—at the 2025 Vascular Annual…
Humacyte announces Symvess ECAT approval from US Defense Logistics Agency
Humacyte announced today that Symvess has been awarded Electronic Catalog (ECAT) listing approval from the U.S. Defense Logistics Agency. ECAT is an internet system that provides the Department of Defense (DOD) and other federal agencies with access to manufacturers’ and…
Presenting a united front to address vascular surgery’s structural and financial challenges
Vascular surgeons must present a unified front in order to address structural and financial challenges facing the specialty, Society for Vascular Surgery (SVS) President-Elect Keith Calligaro, MD, said in summing up this year’s E. Stanley Crawford Critical Issues Forum at…
RESCUE II results on Thrombolex’s Bashir endovascular catheter for PE published
Thrombolex recently announced the publication of RESCUE-II study results in JACC: Advances. The RESCUE-II study was a single-centre, prospective study evaluating the safety and feasibility of on-the-table (OTT) pharmacomechanical lysis (PML) without postprocedural infusion when treating patients with acute intermediate-risk…